Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics

Addiction Biology

Volumn 17, Issue 2, 2012, Pages 490-503

  Rominger, Axel ^a   Cumming, Paul ^a   Xiong, Guoming ^a   Koller, Gabriele ^a   Böning, Guido ^a   Wulff, Melanie ^a   Zwergal, Andreas ^a   Förster, Stefan ^b   Reilhac, Anthonin ^c   Munk, Ole ^d   Soyka, Michael ^a,e   Wängler, Björn ^a   Bartenstein, Peter ^a   La Fougère, Christian ^a   Pogarell, Oliver ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c CERMEP IMAGERIE DU VIVANT   (France)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e Private Hospital Meiringen   (Switzerland)

Author keywords

18F Fallypride; addiction; alcoholism; detoxification; dopamine D 2 3 receptor; PET

Indexed keywords

ALCOHOL; CARBON 13; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; FALLYPRIDE F 18; FLUORINE 18; LIGAND; RACLOPRIDE; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; N ((1 ALLYL 2 PYRROLIDINYL)METHYL) 5 (3 FLUOROPROPYL) 2,3 DIMETHOXYBENZAMIDE; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; PYRROLIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DETOXIFICATION; DOPAMINERGIC SYSTEM; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; INSULA; MALE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL CORTEX; THALAMUS; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; CLUSTER ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BENZAMIDES; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CORPUS STRIATUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TEMPERANCE; YOUNG ADULT;

EID: 84857655747     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00355.x     Document Type: Article

References (55)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M, (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155: 761-767. (Pubitemid 28252654)
2. Anton RF, Moak DH, Latham PK, (1996) The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53: 225-231. (Pubitemid 26085204)
3. Aupee AM, Desgranges B, Eustache F, Lalevee C, de la Sayette V, Viader F, Baron JC, (2001) Voxel-based mapping of brain hypometabolism in permanent amnesia with PET. Neuroimage 13: 1164-1173. (Pubitemid 32553547)
4. Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A, (2003) Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49: 226-231. (Pubitemid 36927963)
5. Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C, (2006) Modeling sensitization to stimulants in humans: an [11C]raclopride/ positron emission tomography study in healthy men. Arch Gen Psychiatry 63: 1386-1395. (Pubitemid 44878522)
6. Comings DE, Blum K, (2000) Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 126: 325-341. (Pubitemid 35461297)
7. Costes N, Dagher A, Larcher K, Evans AC, Collins DL, Reilhac A, (2009) Motion correction of multi-frame PET data in neuroreceptor mapping: simulation based validation. Neuroimage 47: 1496-1505.
8. Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A, Ryu YH, Sprague KE, Pike VW, Fujita M, (2008) Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse 62: 399-408. (Pubitemid 351614765)
9. Cumming P, (2011) Absolute abundances and affinity states of dopamine receptors in mammalian brain: a review. Synapse 65: 892-909.
10. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA, (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49: 81-96. (Pubitemid 32119502)
11. Fehr C, Yakushev I, Hohmann N, Buchholz HG, Landvogt C, Deckers H, Eberhardt A, Klager M, Smolka MN, Scheurich A, Dielentheis T, Schmidt LG, Rosch F, Bartenstein P, Grunder G, Schreckenberger M, (2008) Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry 165: 507-514. (Pubitemid 351694294)
12. la Fougere C, Popperl G, Levin J, Wangler B, Boning G, Uebleis C, Cumming P, Bartenstein P, Botzel K, Tatsch K, (2010) The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic Parkinsonian syndromes. J Nucl Med 51: 581-587.
13. Garavan H, (2010) Insula and drug cravings. Brain Struct Funct 214: 593-601.
14. Grillon C, Sinha R, Ameli R, O'Malley SS, (2000) Effects of alcohol on baseline startle and prepulse inhibition in young men at risk for alcoholism and/or anxiety disorders. J Stud Alcohol 61: 46-54. (Pubitemid 30005058)
15. Guardia J, Catafau AM, Batlle F, Martin JC, Segura L, Gonzalvo B, Prat G, Carrio I, Casas M, (2000) Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. Am J Psychiatry 157: 127-129. (Pubitemid 30027434)
16. Heinz A, Siessmeier T, Wrase J, Buchholz HG, Grunder G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P, (2005) Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry 162: 1515-1520. (Pubitemid 41105567)
17. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser SM, Flor H, Braus DF, Buchholz HG, Grunder G, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P, (2004) Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161: 1783-1789. (Pubitemid 39314671)
18. Hietala J, Kuoppamaki M, Nagren K, Lehikoinen P, Syvalahti E, (1997) Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man-a positron emission tomography study. Psychopharmacology (Berl) 132: 361-365. (Pubitemid 27373477)
19. Hietala J, West C, Syvalahti E, Nagren K, Lehikoinen P, Sonninen P, Ruotsalainen U, (1994) Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) 116: 285-290. (Pubitemid 24345278)
20. Ichise M, Ballinger JR, Tanaka F, Moscovitch M, St George-Hyslop PH, Raphael D, Freedman M, (1998) Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med 39: 1511-1518. (Pubitemid 28459877)
21. Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A, (2010) Striatal and extrastriatal dopamine D(2)/D(3) receptors in schizophrenia evaluated with [(18)F]fallypride positron emission tomography. Biol Psychiatry 68: 634-641.
22. Koob GF, Le Moal M, (2008) Addiction and the brain antireward system. Annu Rev Psychol 59: 29-53.
23. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL, (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16: 834-840. (Pubitemid 26292051)
24. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH, (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239. (Pubitemid 36918259)
25. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Laruelle M, Abi-Dargham A, (2005) Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58: 779-786. (Pubitemid 41677416)
26. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M, (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285-300. (Pubitemid 36307573)
27. Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, Mantil J, (2002) Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 46: 170-188. (Pubitemid 35155170)
28. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M, (2009) Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D(2/3) radiotracers [(11)C]FLB 457 and [(11)C]fallypride. Synapse 63: 447-461.
29. Neiman J, Litton JE, (2000) Reduced [11C]flumazenil radioligand binding in the thalamus in alcoholics. Addict Biol 5: 97-99. (Pubitemid 30085439)
30. Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brucke T, (1997) Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease. J Nucl Med 38: 1711-1717. (Pubitemid 27495516)
31. Repo E, Kuikka JT, Bergstrom KA, Karhu J, Hiltunen J, Tiihonen J, (1999) Dopamine transporter and D2-receptor density in late-onset alcoholism. Psychopharmacology (Berl) 147: 314-318. (Pubitemid 30010553)
32. Rominger A, Wagner E, Mille E, Boning G, Esmaeilzadeh M, Wangler B, Gildehaus FJ, Nowak S, Bruche A, Tatsch K, Bartenstein P, Cumming P, (2010) Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse. Synapse 64: 313-322.
33. Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, Schirrmacher R, Rosch F, Schreckenberger M, Wong DF, Cumming P, Grunder G, Bartenstein P, (2005) Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med 46: 964-972. (Pubitemid 43733511)
34. Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J, Hackett E, Bae SA, Laruelle M, Abi-Dargham A, (2010) Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse 64: 350-362.
35. Soyka M, Zetzsche T, Dresel S, Tatsch K, (2000) FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis. J Neuropsychiatry Clin Neurosci 12: 287-288. (Pubitemid 30303791)
36. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A, (1996) Relationship between alcohol withdrawal seizures and temporal lobe white matter volume deficits. Alcohol Clin Exp Res 20: 348-354. (Pubitemid 26117909)
37. Thanos PK, Volkow ND, Freimuth P, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R, (2001) Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 78: 1094-1103. (Pubitemid 32823158)
38. Tupala E, Hall H, Bergstrom K, Mantere T, Rasanen P, Sarkioja T, Tiihonen J, (2003) Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Hum Brain Mapp 20: 91-102. (Pubitemid 37255116)
39. Vernaleken I, Fellows C, Janouschek H, Brocheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rosch F, Schafer W, Wong DF, Grunder G, (2008) Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). J Clin Psychopharmacol 28: 608-617.
40. Vilkman H, Kajander J, Aalto S, Vahlberg T, Nagren K, Allonen T, Syvalahti E, Hietala J, (2009) The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study. Psychiatry Res 174: 130-137.
41. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N, (2001) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021. (Pubitemid 33104107)
42. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F, (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56 (Suppl. 1): 3-8.
43. Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS, Hitzemann R, Smith G, Logan J, (1998) Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 155: 344-349. (Pubitemid 28114890)
44. Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK, (2006) High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 63: 999-1008. (Pubitemid 44330458)
45. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K, (1996) Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20: 1594-1598. (Pubitemid 26428110)
46. Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Overall JE, Burr G, Wolf AP, (1994) Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry 151: 178-183. (Pubitemid 24053095)
47. Volkow ND, Wang GJ, Maynard L, Fowler JS, Jayne B, Telang F, Logan J, Ding YS, Gatley SJ, Hitzemann R, Wong C, Pappas N, (2002) Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res 116: 163-172. (Pubitemid 35441320)
48. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C, (2007) Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 27: 12700-12706. (Pubitemid 350127825)
49. Wang GJ, Volkow ND, Fowler JS, Logan J, Gur R, Netusil N, Hitzemann RJ, Pappas NS, (1996) Age associated decrements in dopamine D2 receptors in thalamus and in temporal insula of human subjects. Life Sci 59: PL31-PL35. (Pubitemid 26198127)
50. Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Muller-Forell W, Piel M, Rosch F, Glaser M, Schreckenberger M, Bartenstein P, (2006) Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Epilepsia 47: 1392-1396. (Pubitemid 44200421)
51. Wobrock T, Falkai P, Schneider-Axmann T, Frommann N, Wolwer W, Gaebel W, (2009) Effects of abstinence on brain morphology in alcoholism: a MRI study. Eur Arch Psychiatry Clin Neurosci 259: 143-150.
52. Wong DF, Brasic JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y, Nandi A, Maris MA, Alexander M, Ye W, Rousset O, Kumar A, Szabo Z, Gjedde A, Grace AA, (2008) Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33: 1239-1251. (Pubitemid 351521728)
53. Wong DF, Pearlson GD, Tune LE, Young LT, Meltzer CC, Dannals RF, Ravert HT, Reith J, Kuhar MJ, Gjedde A, (1997) Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab 17: 331-342. (Pubitemid 27161376)
54. Yoder KK, Kareken DA, Seyoum RA, O'Connor SJ, Wang C, Zheng QH, Mock B, Morris ED, (2005) Dopamine D(2) receptor availability is associated with subjective responses to alcohol. Alcohol Clin Exp Res 29: 965-970. (Pubitemid 40934200)
55. Yoder KK, Morris ED, Constantinescu CC, Cheng TE, Normandin MD, O'Connor SJ, Kareken DA, (2009) When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamine. Alcohol Clin Exp Res 33: 139-149.